For further details see:
Numinus Wellness reports FQ2 resultshome / stock / lkysf / lkysf news
For further details see:
Numinus Wellness reports FQ2 resultsMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com View original content to download multimedia: https://newsdirect.com/news/proactive-research-analyst-on-numinus-wellness-annual-results-434599538
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health advocates are call...
VANCOUVER, BC, Nov. 25, 2021 /PRNewswire/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted thera...